| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/12/2007 | EP1830924A1 Prevention of thrombus formation and/or stabilization |
| 09/12/2007 | EP1830881A2 Combining therapies targeting multiple toll-like receptors and use thereof |
| 09/12/2007 | EP1830880A2 Multi-route administration of immune response modifier compounds |
| 09/12/2007 | EP1830878A2 Compositions comprising opa protein epitopes |
| 09/12/2007 | EP1830877A2 Recombinant bcg strains with attenuated immunosuppresive properties |
| 09/12/2007 | EP1830876A2 Treatment for cutaneous metastases |
| 09/12/2007 | EP1830875A2 Il-15 antigen arrays and uses thereof |
| 09/12/2007 | EP1830867A2 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 09/12/2007 | EP1481053B1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1320542B9 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 09/12/2007 | EP1307564B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/12/2007 | EP1212366B1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 09/12/2007 | EP1024834B1 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 09/12/2007 | EP0970127B1 Induction of immunological tolerance to a therapeutic antibody using variants of the said therapeutic antibody |
| 09/12/2007 | EP0651807B1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 09/12/2007 | CN101035897A Vaccine for prevention and treatment of HIV-infection |
| 09/12/2007 | CN101035810A Modulators of hepatocyte growth factor activator |
| 09/12/2007 | CN101035808A Humanized anti-CMET antagonists |
| 09/12/2007 | CN101035807A Diagnosis and treatment of SIGLEC-6 associated diseases |
| 09/12/2007 | CN101035645A Methods for processing holes by moving precisely timed laser pulses in circular and spiral trajectories |
| 09/12/2007 | CN101035566A Immunotherapy of autoimmune disorders |
| 09/12/2007 | CN101035561A Compositions as adjuvants to improve immune responses to vaccines and methods of use |
| 09/12/2007 | CN101035560A Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis c virus |
| 09/12/2007 | CN101035559A Multivalent avian influenza vaccines |
| 09/12/2007 | CN101035558A Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 09/12/2007 | CN101035546A Glycosylceramide adjuvant for saccharide antigens |
| 09/12/2007 | CN101033468A Helicobacter pylori urease B subunit B cell antigen epitope polypeptide, identification method and application |
| 09/12/2007 | CN101033464A Recombination adenovirus for expressing human particle cytolysin and its preparing method and use |
| 09/12/2007 | CN101032622A Application of transspecific factors of alpha-fetoprotein in the producing of medicine of inducing masculine liver cancer cells of alpha-fetoprotein into death |
| 09/12/2007 | CN101032621A Preparing method of infectious gastroenteritis virus monoclonal antibody immunity biological agent of pigs |
| 09/12/2007 | CN100336558C Method for preparing cow foremilk immune globulin microcapsulation |
| 09/11/2007 | US7268227 Posh nucleic acids, polypeptides and related methods |
| 09/11/2007 | US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268118 Thymosin β4 compositions |
| 09/11/2007 | US7268112 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 09/11/2007 | US7267977 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 09/11/2007 | US7267963 Modified plant viruses and methods of use thereof |
| 09/11/2007 | US7267960 Therapy for disease, infections; antiinflammatory agents; modulate cellular adhesion molecules; generation human dendritic cells; anticancer agents; bactericides |
| 09/11/2007 | US7267941 A viricide polypeptide having >70% sequence identity to native cyanovirin-N and having strategic cysteine and arginine replacements is covalent modified by water-soluble Polyoxyethylene Glycol to extend half-life, reduce toxicity/immunogenicity, improve pharmacokinetics/bioavailability; envelope viruses |
| 09/11/2007 | US7267940 HSV-2 type-specific immunoassays using glycoprotein G2 peptides |
| 09/11/2007 | US7267824 Veterinary medicine; induce immunology response |
| 09/11/2007 | US7267823 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response |
| 09/11/2007 | US7267821 Antitumor agents; leukemia; |
| 09/11/2007 | US7267820 Detecting in body fluid an autoantibody to epitopes of muscle tyrosine kinase |
| 09/11/2007 | US7267819 Composition comprising and method of using angiopoietin-like protein 3 Angptl3 |
| 09/11/2007 | US7267815 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 09/11/2007 | CA2319571C Methods and compositions for detection and diagnosis of infectious diseases |
| 09/11/2007 | CA2196097C Secreted viral proteins useful for vaccines and diagnostics |
| 09/11/2007 | CA2164498C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 09/07/2007 | WO2007100755A1 Method for decreasing the toxic effects of nicotine on fetuses in pregnant women |
| 09/07/2007 | WO2007100643A2 Methods of using antibodies against human il-22 |
| 09/07/2007 | WO2007100580A2 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 09/07/2007 | WO2007100543A2 Extracellular matrix to treat malignancy in mammals |
| 09/07/2007 | WO2007100154A1 Immuno-cell therapy for allergic disease using regulatory dendritic cell |
| 09/07/2007 | WO2007100058A1 Rheumatoid arthritis test method and treating method |
| 09/07/2007 | WO2007099988A1 α-1,6-FUCOSYLTRANSFERASE MUTANT AND USE THEREOF |
| 09/07/2007 | WO2007099869A1 Therapeutic and preventive agent for hcv |
| 09/07/2007 | WO2007099446A2 Virosome-like vesicles comprising gp41-derived antigens |
| 09/07/2007 | WO2007099387A1 Virosome-like vesicles comprising gp41-derived antigens |
| 09/07/2007 | WO2007099346A1 Binding members for ghrelin |
| 09/07/2007 | WO2007098934A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/07/2007 | WO2007098717A2 Chimeric vaccine antigens against classical swine fever virus |
| 09/07/2007 | WO2007098607A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | WO2007098604A1 Preventing il-2 mediated inflammation in epithelial cells |
| 09/07/2007 | WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | WO2007081879A3 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 09/07/2007 | WO2007077028A3 Antibodies directed to her-3 and uses thereof |
| 09/07/2007 | WO2007075915A3 Monoclonal antibodies against orthopoxviruses |
| 09/07/2007 | WO2007075914A3 Monoclonal antibodies against orthopoxviruses |
| 09/07/2007 | WO2007072032A3 Neisseria meningitidis vaccines and their use |
| 09/07/2007 | WO2007071997A3 Method of eliciting immune response |
| 09/07/2007 | WO2007062832A3 Vaccines containing non-live antigenic vectors |
| 09/07/2007 | WO2007060240A3 Method for demonstrating presence or absence of markers (eef1a1 or mark3 )associated with the presence and/or the chemosensitivity of tumors |
| 09/07/2007 | WO2007055952A3 Process for producing stable hiv th-ctl peptides |
| 09/07/2007 | WO2007055894A3 Preparation of vaccine master cell lines using recombinant plant suspension cultures |
| 09/07/2007 | WO2007052163A3 Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment |
| 09/07/2007 | WO2007042827A3 Treatment and diagnosis of obligate intracellular pathogens |
| 09/07/2007 | WO2007038392A3 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| 09/07/2007 | WO2006093923A8 Treatment of bone disorders |
| 09/07/2007 | WO2006020541A3 Methods for synthesizing polypeptides |
| 09/07/2007 | WO2005051313A3 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 09/07/2007 | WO2005011605A3 Combination therapies for multiple sclerosis |
| 09/07/2007 | CA2651796A1 Identification and use of novopeptides for the treatment of cancer |
| 09/07/2007 | CA2644595A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/07/2007 | CA2644513A1 Preventing il-2 mediated inflammation in epithelial cells |
| 09/07/2007 | CA2644282A1 Virosome-like vesicles comprising gp41-derived antigens |
| 09/07/2007 | CA2643708A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | CA2642994A1 Immunogenic page-4 peptides and methods of use |
| 09/07/2007 | CA2642984A1 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 09/07/2007 | CA2642848A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | CA2642570A1 Methods of using antibodies against human il-22 |
| 09/07/2007 | CA2641513A1 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/07/2007 | CA2638832A1 Chimeric vaccine antigens against the avian influenza virus |
| 09/07/2007 | CA2638830A1 Chimeric vaccine antigens against classical swine fever virus |
| 09/07/2007 | CA2638757A1 Chimeric adenoviral vectors |
| 09/07/2007 | CA2617600A1 Attenuated reovirus |
| 09/06/2007 | US20070208167 Compounds and methods for modulating activation of NF-kappaB |